港大深圳医院添国家级名片

Core Viewpoint - Hong Kong University Shenzhen Hospital has been recognized as a "Demonstration Center for Standardized Diagnosis and Treatment of Systemic Lupus Erythematosus (SLE)" by the National Clinical Medical Research Center for Skin and Immune Diseases, marking a significant advancement in the treatment of autoimmune diseases in the Greater Bay Area [1][2] Group 1 - The hospital is the first in Shenzhen to receive this certification, highlighting its role in standardizing and collaborating on the treatment of autoimmune diseases [1] - The SLE clinic at the hospital has seen an annual patient volume of 4,000 in recent years, demonstrating its capacity and expertise in managing severe lupus cases [1] - The establishment of the national-level demonstration center is viewed as a recognition of the department's past work and a hopeful sign for future development in the field [1] Group 2 - The introduction of the "Hong Kong-Macau Drug and Device Pass" policy has allowed the hospital to successfully import the innovative drug Avelumab for adult patients with moderate to severe active SLE, providing new treatment options [1] - The director of the National Clinical Medical Research Center emphasized that the standardization of SLE treatment is crucial for improving patient survival rates and quality of life, and expressed hope that the hospital will serve as a benchmark for national lupus treatment [2] - The hospital's vice president stated that the unveiling of the center is not only a milestone for the hospital but also a response to national calls for enhancing the standardization of medical resources in the region [2]